❉ Buffybot wonderful businesses, fair prices

← back

EW Edwards Lifesciences

healthcare · valued with sonnet medium conviction · 2026-07-24

HOLD
good · 80 ▟ wide moat circle of competence: in ✓ would own for a decade trend flat · +0.5% vs 200-DMA
Owner-earnings value$43.83
Price$83.82
Margin of safety -47.7%

Wonderful regulatory-moat medtech, but price already bakes in ~25% growth versus a realistic ~10%.

The business

Edwards Lifesciences makes surgical and transcatheter heart valves (TAVR, mitral/tricuspid) and hemodynamic monitoring systems, selling to hospitals and cardiac surgeons/cardiologists who implant devices in a recurring, high-clinical-stakes replacement cycle.

Quality gate · 80/100

Returns on capital 20.2/30
Consistency 18.8/22
Margins / pricing power 15.9/16
Balance sheet 16.0/16
Cash conversion 3.1/10
Capital allocation 5.6/6
Median ROIC14.1%
Gross margin77.9%
Net debt / EBITDA-1.4x
FCF conversion39%
Share count / yr-1.5%
Profitable years4/4

Moat & management

Moat ▟ wide moat
Sourceregulatory
Trajectorystable
Managementexcellent

Structural heart devices require years of clinical trials, FDA approval, and physician retraining/proctoring before adoption, creating durable switching costs and regulatory barriers; Edwards has iterated TAVR platforms (Sapien) for over a decade maintaining leadership, though Medtronic, Abbott, and Boston Scientific are credible competitors in adjacent structural heart segments (mitral/tricuspid), keeping the moat from widening further.

Management has consistently reinvested heavily in R&D/clinical trials to defend TAVR leadership and expand into mitral/tricuspid, while shrinking share count (-1.5% CAGR) and maintaining a net-cash balance sheet rather than over-levering for M&A.

Owner-earnings inputs

Owner earnings (TTM)1.09B
Owner-earnings yield2.3%
Free-cash-flow yield2.3%
Growth used (normalized)10.0%
Market-implied growth (reverse DCF)25.0%
Terminal growth3.0%
Discount rate (hurdle)9.0%

Projected owner earnings

YrOwner earningsGrowthPV
11.10B 10.0%1.01B
21.20B 9.2%1.01B
31.31B 8.4%1.01B
41.41B 7.7%996.15M
51.50B 6.9%976.86M
61.59B 6.1%950.96M
71.68B 5.3%918.98M
81.76B 4.6%881.50M
91.82B 3.8%839.27M
101.88B 3.0%793.07M

Key risks

  • TAVR/TMTT market share erosion from Medtronic, Abbott, Boston Scientific in mitral/tricuspid
  • Reimbursement or hospital capital-spending pressure slowing procedure volume growth
  • Pipeline/clinical trial setbacks (e.g., in newer transcatheter mitral/tricuspid programs) delaying next growth leg
  • FCF conversion (0.39) well below net income, indicating working-capital or capex intensity that could persist

Catalysts

  • Continued TAVR indication expansion (younger/lower-risk patients) and international penetration
  • TMTT (mitral/tricuspid) platform reaching commercial scale as a new growth pillar
  • Structural heart category growth as an aging population increases valve replacement volumes

Recent news

score · 8 articles

  • Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ...
  • Edwards Lifesciences Q2 Earnings Call Highlights
  • Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
  • Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth
  • Edwards Stock Launches As Heart-Valve Replacements Beat On
  • Edwards' Q2 Earnings on the Horizon: What's in the Cards?
  • Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
  • FTC Says Henkel Deal Would Merge ‘Coke and Pepsi’ of Adhesives

⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Net cash 2.2B credited to value (interest stripped from owner earnings to avoid double-counting). · Price pays for ~25%/yr owner-earnings growth over 10y (reverse DCF); model credits 10%. · Rich vs our conservative value, but a quality business is not a short — stance is WAIT for a better price, not sell.

History

DateQualityPriceValueMoSRating
2026-10-28 80 $90.82 $43.63 -52.0% HOLD
2026-10-27 80 $90.56 $43.63 -51.8% HOLD
2026-10-26 80 $89.07 $43.63 -51.0% HOLD
2026-10-23 80 $90.09 $43.63 -51.6% HOLD
2026-10-22 80 $88.40 $43.63 -50.6% HOLD
2026-10-21 80 $88.29 $43.63 -50.6% HOLD
2026-10-20 80 $87.22 $43.63 -50.0% HOLD
2026-10-19 80 $86.60 $43.63 -49.6% HOLD
2026-10-16 80 $88.10 $43.63 -50.5% HOLD
2026-10-15 80 $86.45 $43.63 -49.5% HOLD
2026-10-14 80 $85.27 $43.63 -48.8% HOLD
2026-10-13 80 $86.39 $43.63 -49.5% HOLD
2026-10-12 80 $85.21 $43.63 -48.8% HOLD
2026-10-09 80 $84.24 $43.63 -48.2% HOLD
2026-10-08 80 $85.78 $43.63 -49.1% HOLD
2026-10-07 80 $86.48 $43.63 -49.5% HOLD
2026-10-06 80 $87.23 $43.63 -50.0% HOLD
2026-10-05 80 $85.15 $43.63 -48.8% HOLD
2026-10-02 80 $85.19 $43.63 -48.8% HOLD
2026-10-01 80 $86.32 $43.63 -49.5% HOLD
2026-09-30 80 $88.08 $43.63 -50.5% HOLD
2026-09-29 80 $86.83 $43.63 -49.8% HOLD
2026-09-28 80 $86.29 $43.63 -49.4% HOLD
2026-09-25 80 $85.73 $43.63 -49.1% HOLD
2026-09-24 80 $86.82 $43.63 -49.7% HOLD
2026-09-23 80 $88.34 $43.63 -50.6% HOLD
2026-09-22 80 $88.34 $43.63 -50.6% HOLD
2026-09-21 80 $88.26 $43.63 -50.6% HOLD
2026-09-18 80 $88.25 $43.63 -50.6% HOLD
2026-09-17 80 $89.28 $43.63 -51.1% HOLD
2026-09-16 80 $85.74 $43.63 -49.1% HOLD
2026-09-15 80 $85.52 $43.63 -49.0% HOLD
2026-09-14 80 $84.37 $43.63 -48.3% HOLD
2026-09-11 80 $86.77 $43.83 -49.5% HOLD
2026-09-10 80 $86.18 $43.83 -49.1% HOLD
2026-09-09 80 $86.72 $43.83 -49.5% HOLD
2026-09-08 80 $89.90 $43.83 -51.2% HOLD
2026-09-07 80 $89.90 $43.83 -51.2% HOLD
2026-09-04 80 $89.78 $43.83 -51.2% HOLD
2026-09-03 80 $90.82 $43.83 -51.7% HOLD
2026-09-02 80 $90.74 $43.83 -51.7% HOLD
2026-09-01 80 $90.75 $43.83 -51.7% HOLD
2026-08-31 80 $90.21 $43.83 -51.4% HOLD
2026-08-28 80 $89.95 $43.83 -51.3% HOLD
2026-08-27 80 $90.78 $43.83 -51.7% HOLD
2026-08-26 80 $90.87 $43.83 -51.8% HOLD
2026-08-25 80 $90.50 $43.83 -51.6% HOLD
2026-08-24 80 $89.79 $43.83 -51.2% HOLD
2026-08-21 80 $89.83 $43.83 -51.2% HOLD
2026-08-20 80 $92.28 $43.83 -52.5% HOLD
2026-08-19 80 $90.98 $43.83 -51.8% HOLD
2026-08-18 80 $91.60 $43.83 -52.2% HOLD
2026-08-17 80 $91.60 $43.83 -52.2% HOLD
2026-08-14 80 $92.56 $43.83 -52.6% HOLD
2026-08-13 80 $93.05 $43.83 -52.9% HOLD
2026-08-12 80 $93.66 $43.83 -53.2% HOLD
2026-08-11 80 $92.03 $43.83 -52.4% HOLD
2026-08-10 80 $89.72 $43.83 -51.1% HOLD
2026-08-07 80 $89.32 $43.83 -50.9% HOLD
2026-08-06 80 $88.97 $43.83 -50.7% HOLD
2026-08-05 80 $89.60 $43.83 -51.1% HOLD
2026-08-04 80 $86.07 $43.83 -49.1% HOLD
2026-08-03 80 $86.07 $43.83 -49.1% HOLD
2026-07-31 80 $86.92 $43.83 -49.6% HOLD
2026-07-30 80 $85.76 $43.83 -48.9% HOLD
2026-07-29 80 $83.04 $43.83 -47.2% HOLD
2026-07-28 80 $83.04 $43.83 -47.2% HOLD
2026-07-27 80 $83.82 $43.83 -47.7% HOLD
2026-07-24 80 $83.82 $43.83 -47.7% HOLD
2026-07-23 80 $84.37 $44.00 -47.9% HOLD
2026-07-22 80 $84.55 $44.00 -48.0% HOLD
2026-07-21 80 $85.00 $44.00 -48.2% HOLD
2026-07-20 80 $85.73 $44.00 -48.7% HOLD
2026-07-17 80 $87.84 $44.00 -49.9% HOLD
2026-07-16 80 $87.27 $44.00 -49.6% HOLD
2026-07-15 80 $91.79 $44.00 -52.1% HOLD
2026-07-14 80 $91.79 $44.00 -52.1% HOLD
2026-07-13 80 $92.21 $44.00 -52.3% HOLD
2026-07-10 80 $91.33 $44.00 -51.8% HOLD
2026-07-09 80 $93.64 $44.00 -53.0% HOLD
2026-07-08 80 $94.82 $44.00 -53.6% HOLD
2026-07-07 80 $95.18 $44.00 -53.8% HOLD
2026-07-06 80 $94.37 $44.00 -53.4% HOLD
2026-07-03 80 $94.37 $44.00 -53.4% HOLD
2026-07-02 80 $91.99 $44.00 -52.2% HOLD
2026-06-25 80 $89.66 $43.42 -51.6% STRONG SELL
2026-06-23 80 $86.95 $43.42 -50.1% STRONG SELL